Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study
DIANA-5
DIANA-5: Randomized Trial to Test the Efficacy of Dietary Change and Physical Activity to Prevent or Delay the Development of Recurrences in Breast Cancer Patients Estimated to be at High Risk of Recurrence Hormonal and Metabolic Reasons
1 other identifier
interventional
1,542
0 countries
N/A
Brief Summary
The investigators recruited 1542 Breast Cancer (BC) patients and to randomize the participants in two groups: 773 have received standard recommendations for healthy lifestyle without, however, any active support; 700 have received a combination of individual and group contacts over the course of one year, including kitchen courses, gym and dance classes, common meals and reinforcing meetings, with emphasis on a comprehensive dietary change including low saturated fat and low refined carbohydrates, and high whole grain cereals and pulses consumption. Compliance have been monitored through weight change and plasma glucose, triglycerides, cholesterol and testosterone. The main analysis will be by intention to treat. Under the hypothesis of reducing recurrence rate by 25% or 33% the statistical power of the study is 80% or, respectively, 90%, (P\<0.05, 5-year follow-up).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2008
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2017
CompletedFirst Submitted
Initial submission to the registry
July 14, 2021
CompletedFirst Posted
Study publicly available on registry
August 25, 2021
CompletedAugust 25, 2021
August 1, 2021
4.3 years
July 14, 2021
August 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction of recurrences
The investigators have been proposing a randomized intervention trial of diet and physical activity to change BC relapse (local, distant), and second ipsilateral or contralateral BC, in BC patients at high risk of recurrence because of biochemical markers of increased risk, namely high serum testosterone and/or high fasting insulin and/or metabolic syndrome. Several other markers of increased recurrence risk are available, such as cancer stage at diagnosis, histological grade, hormonal receptors and other gene expression profile. All these will be registered, but the investigators are specifically interested in markers of the host that can be modified through life-style.
Baseline, fifth year
Secondary Outcomes (7)
Modification lifestyle and Metabolic Syndrome (MetS)
Baseline, first year
Modification lifestyle and Body Mass Index (BMI)
Baseline, first year
Modification lifestyle and Testosterone
Baseline, first year
Modification lifestyle and Insulin
Baseline, first year
Development other cancer
Baseline, fifth year
- +2 more secondary outcomes
Study Arms (2)
Intervention group: on diet and physical activity
EXPERIMENTALIndividual advice on diet and on physical activity Kitchen courses to teach basic Mediterranean and macrobiotic recipes (two 1-day course plus ten 3-h courses associated with common dinner) (15-20 participants at a time) Fortnightly common lunch or dinner (50-60 participant at a time) Basic gymnastic course (twelve - monthly- 2-hour courses) * Study newsletter, with scientific information, kitchen recipes, study facilities * Periodic conferences on diet and health * Periodic reinforcement meetings with common meals, gymnastic sessions, and dancing, after the first year * Periodic body weight assessment (weekly self-measurement and monthly measurement at the study center) * Discounted rate for advanced kitchen courses * Psychological support groups
Control group: only public recommendations on lifestyle
EXPERIMENTAL1. Invitation leaflet, explaining the rationale of the study and including basic life-style recommendations, based on the 1997 World Cancer Research Fund recommendations (to be updated in 2007) and the Italian National Institute of Nutrition food pyramid. 2. Dissemination of the information on the study by media 3. Yearly follow-up questionnaire on breast events and dietary and physical activity chang
Interventions
The intervention wanted to increase physical activity, controlling weight, promoting healthy diet. 1. Physical activity: achieve and maintain regular participation in a moderate intensity physical activity program of 210 minutes/week (30 min on average per day) over at least 3 days /week; decrease sedentary behaviors by 30 minutes/day on at least 5 days/week 2. Weight control: reducing energy intake relative to expenditure is the primary dietary focus for promoting weight loss in overweight or obese participants, and maintaining a healthy energy balance is the primary focus for normal weight participants. Participants will be encouraged to include whole grains and high-fiber vegetables 3. Healthy diet: reducing calorie intake, through the preferred consumptions of unrefined cereals, pulses and vegetables, reducing high glycemic index food and high insulinemic foods, such as sugar and milk; reducing sources of saturated fat and animal protein (except fish)
1. Invitation leaflet, explaining the rationale of the study and including basic life-style recommendations, based on the 1997 World Cancer Research Fund recommendations (to be updated in 2007) and the Italian National Institute of Nutrition food pyramid. 2. Dissemination of the information on the study by media 3. Yearly follow-up questionnaire on breast events and dietary and physical activity chang
Eligibility Criteria
You may qualify if:
- Mastectomy or conservative surgery for invasive breast cancer, any type, in the last five years (the investigators recruited mostly patients at the time or after surgery, when chemotherapy has been concluded and hormonal therapy, if necessary, has been started)
- Absence of signs or symptoms suggestive of recurrences
- Presence of one or more of the following endocrine/metabolic indicators: serum testosterone level ≥ 0.4 ng/ml (1 nmol/ml), corresponding to the median value in BC patients, or serum insulin ≥ 50 pmol/L, corresponding to the upper quartile of insulin distribution in Breast Cancer patients, or metabolic syndrome, present in about 15% of Breast Cancer patients.
You may not qualify if:
- Metastatic disease or previous relapse
- Age \>70
- Physical or mental handicaps that would have impeded to engage in moderate physical activity or participate in kitchen classes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milanolead
- Associazione Italiana per la Ricerca sul Cancrocollaborator
- European Institute of Oncologycollaborator
- Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemontecollaborator
- Federico II Universitycollaborator
- IRCCS Cancer Referral Center of Basilicatacollaborator
- ARNAS Civico Di Cristina Benfratelli Hospitalcollaborator
- Lega Italiana per la Lotta contro i Tumoricollaborator
- Azienda Socio Sanitaria Territoriale di Mantovacollaborator
- Ministero della Salute, Italycollaborator
Related Publications (7)
Roveda E, Bruno E, Galasso L, Mule A, Castelli L, Villarini A, Caumo A, Esposito F, Montaruli A, Pasanisi P. Rest-activity circadian rhythm in breast cancer survivors at 5 years after the primary diagnosis. Chronobiol Int. 2019 Aug;36(8):1156-1165. doi: 10.1080/07420528.2019.1621330. Epub 2019 Jun 10.
PMID: 31177874RESULTRoveda E, Vitale JA, Bruno E, Montaruli A, Pasanisi P, Villarini A, Gargano G, Galasso L, Berrino F, Caumo A, Carandente F. Protective Effect of Aerobic Physical Activity on Sleep Behavior in Breast Cancer Survivors. Integr Cancer Ther. 2017 Mar;16(1):21-31. doi: 10.1177/1534735416651719. Epub 2016 Jun 1.
PMID: 27252076RESULTBruno E, Gargano G, Villarini A, Traina A, Johansson H, Mano MP, Santucci De Magistris M, Simeoni M, Consolaro E, Mercandino A, Barbero M, Galasso R, Bassi MC, Zarcone M, Zagallo E, Venturelli E, Bellegotti M, Berrino F, Pasanisi P. Adherence to WCRF/AICR cancer prevention recommendations and metabolic syndrome in breast cancer patients. Int J Cancer. 2016 Jan 1;138(1):237-44. doi: 10.1002/ijc.29689. Epub 2015 Jul 28.
PMID: 26175188RESULTBerrino F, Villarini A, Traina A, Bonanni B, Panico S, Mano MP, Mercandino A, Galasso R, Barbero M, Simeoni M, Bassi MC, Consolaro E, Johansson H, Zarcone M, Bruno E, Gargano G, Venturelli E, Pasanisi P. Metabolic syndrome and breast cancer prognosis. Breast Cancer Res Treat. 2014 Aug;147(1):159-65. doi: 10.1007/s10549-014-3076-6. Epub 2014 Aug 8.
PMID: 25104441RESULTVillarini A, Pasanisi P, Traina A, Mano MP, Bonanni B, Panico S, Scipioni C, Galasso R, Paduos A, Simeoni M, Bellotti E, Barbero M, Macellari G, Venturelli E, Raimondi M, Bruno E, Gargano G, Fornaciari G, Morelli D, Seregni E, Krogh V, Berrino F. Lifestyle and breast cancer recurrences: the DIANA-5 trial. Tumori. 2012 Jan-Feb;98(1):1-18. doi: 10.1177/030089161209800101.
PMID: 22495696RESULTDjuric O, Bonvicini L, Pellegrini M, Bruno E, Pasanisi P, Gargano G, Curtosi P, Berrino F, Giorgi Rossi P, Villarini A. Diet, body composition and metabolic and hormonal profile in women at high risk of breast cancer recurrence: A secondary mediation analysis of the DIANA-5 trial. Clin Nutr. 2026 Jan;56:106537. doi: 10.1016/j.clnu.2025.11.021. Epub 2025 Dec 4.
PMID: 41483481DERIVEDDe Santi M, Annibalini G, Marano G, Biganzoli G, Venturelli E, Pellegrini M, Lucertini F, Brandi G, Biganzoli E, Barbieri E, Villarini A. Association between metabolic syndrome, insulin resistance, and IGF-1 in breast cancer survivors of DIANA-5 study. J Cancer Res Clin Oncol. 2023 Sep;149(11):8639-8648. doi: 10.1007/s00432-023-04755-6. Epub 2023 Apr 27.
PMID: 37106164DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ANNA VILLARINI, PhD
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Biologist, Nutritionist, PhD and Senior researcher
Study Record Dates
First Submitted
July 14, 2021
First Posted
August 25, 2021
Study Start
June 1, 2008
Primary Completion
September 30, 2012
Study Completion
September 30, 2017
Last Updated
August 25, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- The data will be become available from baseline up to 10 years after study the end of recruitment (2027) for all coordinators of collaborating centers
- Access Criteria
- The data are available on the National Cancer Institute of MILANO (Foundation-Institute of Hospitalization and Scientific Care), network managed
The study protocol, dataset, statistical analysis plan, informed consent form and clinical study report were discussed through meetings held with all the collaborating centers. The individual participant data (IPD) were delivered to the coordinators of the individual centers in coded anonymous.